{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:26:07Z","timestamp":1784849167218,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10067-023-06548-1","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T08:15:29Z","timestamp":1676621729000},"page":"1537-1544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study"],"prefix":"10.1007","volume":"42","author":[{"given":"Alireza","family":"Khabbazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Gadakchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Moslemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Khalaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Esalatmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Ziarati Yazdeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrzad","family":"Hajialilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0176-5438","authenticated-orcid":false,"given":"Aida","family":"Malek Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"issue":"2","key":"6548_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/ijms23020905","volume":"23","author":"S Jang","year":"2022","unstructured":"Jang S, Kwon EJ, Lee JJ (2022) Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci 23(2):905","journal-title":"Int J Mol Sci"},{"issue":"6937","key":"6548_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423(6937):356\u2013361","journal-title":"Nature"},{"issue":"4","key":"6548_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631\u2013637","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6548_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landewe RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A et al (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79(6):685\u2013699","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6548_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/acr.20021","volume":"62","author":"LHD Tuyl","year":"2010","unstructured":"Tuyl LHD, Felson DT, Wells G, Smolen J, Zhang B, Boers M, American College of Rheumatology, European League against Rheumatism Committee to Define Remission for Clinical Trials (2010) Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken) 62(1):108\u2013117","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"6548_CR6","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/annrheumdis-2012-201893","volume":"71","author":"K Raza","year":"2012","unstructured":"Raza K, Saber TP, Kvien TK, Tak PP, Gerlag DM (2012) Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials. Ann Rheum Dis 71(12):1921\u20131923","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6548_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/acr.23016","volume":"69","author":"P Hamann","year":"2017","unstructured":"Hamann P, Holland R, Hyrich K, Pauling JD, Shaddick G, Nightingale A, McHugh N (2017) Factors associated with sustained remission in rheumatoid arthritis in patients treated with anti-tumor necrosis factor (anti-TNF). Arthritis Care Res (Hoboken) 69(6):783\u2013793","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6548_CR8","first-page":"1","volume":"0","author":"M Zen","year":"2015","unstructured":"Zen M, Iaccarino L, Gatto M, Bettio S, Nalotto L, Ghirardello A, Punzi L, Doria A (2015) Prolonged remission in Caucasian patients with SLE: prevalence and outcomes. Ann Rheum Dis 0:1\u20136","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6548_CR9","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1080\/14397595.2021.1886623","volume":"31","author":"A Malek Mahdavi","year":"2021","unstructured":"Malek Mahdavi A, Khabbazi A, Hajialilo M (2021) Long-term outcome and predictors of remission in Beh\u00e7et\u2019s disease in daily practice. Mod Rheumatol 31(6):1148\u20131157","journal-title":"Mod Rheumatol"},{"key":"6548_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00296-019-04248-1","volume":"39","author":"D Prasanna Misra","year":"2019","unstructured":"Prasanna Misra D, Agarwal V (2019) Real-world evidence in rheumatic diseases: relevance and lessons learnt. Rheumatol Int 39:403\u2013416","journal-title":"Rheumatol Int"},{"key":"6548_CR11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/art.1780241012","volume":"24","author":"RS Pinals","year":"1981","unstructured":"Pinals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308\u20131315","journal-title":"Arthritis Rheum"},{"issue":"11","key":"6548_CR12","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1007\/s10067-021-05831-3","volume":"40","author":"S Ebrahimian","year":"2021","unstructured":"Ebrahimian S, Salami A, Malek Mahdavi A, Esalatmanesh K, Khabbazi A, Hajialilo M (2021) Can treating rheumatoid arthritis with disease-modifying antirheumatic drugs at the window of opportunity with tight control strategy lead to long-term remission and medications free remission in real-world clinical practice? A cohort study. Clin Rheumatol 40(11):4485\u20134491","journal-title":"Clin Rheumatol"},{"issue":"5","key":"6548_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to Medication. N Engl J Med 353(5):487\u2013497","journal-title":"N Engl J Med"},{"issue":"1","key":"6548_CR14","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/s41598-022-06584-y","volume":"12","author":"G Larid","year":"2022","unstructured":"Larid G, Vix J, Garlantezec R, Loppin E, Gervais E (2022) Increased remission with fewer corticosteroids and more biologics in rheumatoid arthritis at 7-year follow-up in real-life conditions. Sci Rep 12(1):2563","journal-title":"Sci Rep"},{"key":"6548_CR15","doi-asserted-by":"publisher","unstructured":"Norvang V, Brinkmann GH, Yoshida K, Lillegraven S, Aga AB, Sexton J et al ARCTIC study group; NOR-VEAC study group (2020) Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat-to-target strategies. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.41232","DOI":"10.1002\/art.41232"},{"issue":"10","key":"6548_CR16","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/art.22943","volume":"56","author":"D Aletaha","year":"2007","unstructured":"Aletaha D, Funovits J, Keystone EC, Smolen JS (2007) Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum 56(10):3226\u20133235","journal-title":"Arthritis Rheum"},{"issue":"11","key":"6548_CR17","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3899\/jrheum.140137","volume":"41","author":"B Kuriya","year":"2014","unstructured":"Kuriya B, Xiong J, Boire G, Haraoui B, Hitchon C, Pope J et al (2014) Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis-results from the Canadian Early Arthritis Cohort (CATCH). J Rheumatol 41(11):2161\u20132166","journal-title":"J Rheumatol"},{"issue":"11","key":"6548_CR18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1111\/1756-185X.12908","volume":"21","author":"S Chandrashekara","year":"2018","unstructured":"Chandrashekara S, Shobha V, Dharmanand BG, Jois R, Kumar S, Mahendranath KM et al (2018) Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study. Int J Rheum Dis 21(11):1977\u20131985","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"6548_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1759720X17740075","volume":"10","author":"S Kobak","year":"2018","unstructured":"Kobak S, Bes C (2018) An autumn tale: geriatric rheumatoid arthritis. Ther Adv Musculoskelet Dis 10(1):3\u201311","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"6548_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/rheumatology\/38.3.228","volume":"38","author":"CT Pease","year":"1999","unstructured":"Pease CT, Bhakta BB, Devlin J, Emery P (1999) Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors. Rheumatology (Oxford) 38(3):228\u2013234","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6548_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13075-022-02952-1","volume":"24","author":"X Li","year":"2022","unstructured":"Li X, Cesta A, Movahedi M, Bombardier C (2022) Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative. Arthritis Res Ther 24(1):255","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"6548_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/art.23247","volume":"59","author":"GR Burmester","year":"2008","unstructured":"Burmester GR, Ferraccioli G, Flipo RM, Monteagudo-S\u00e1ez I, Unnebrink K, Kary S et al (2008) Clinical remission and\/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study. Arthritis Rheum 59(1):32\u201341","journal-title":"Arthritis Rheum"},{"issue":"8","key":"6548_CR23","first-page":"1670","volume":"34","author":"L Mancarella","year":"2007","unstructured":"Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PS, Ferrante A, Malesci D et al (2007) Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol 34(8):1670\u20131673","journal-title":"J Rheumatol"},{"key":"6548_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002110","author":"N Jiang","year":"2022","unstructured":"Jiang N, Li Q, Li H, Fang Y, Wu L, Duan X et al (2022) Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients. Chin Med J (Engl). https:\/\/doi.org\/10.1097\/CM9.0000000000002110","journal-title":"Chin Med J (Engl)"},{"key":"6548_CR25","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/art.24661","volume":"60","author":"D van der Woude","year":"2009","unstructured":"van der Woude D, Young A, Jayakumar K et al (2009) Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 60:2262\u20132271","journal-title":"Arthritis Rheum"},{"key":"6548_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/ard.2010.136556","volume":"70","author":"NB Klarenbeek","year":"2011","unstructured":"Klarenbeek NB, van der KooijSM G-Y et al (2011) Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study. Ann Rheum Dis 70:315\u2013319","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6548_CR27","doi-asserted-by":"publisher","first-page":"e000738","DOI":"10.1136\/rmdopen-2018-000738","volume":"4","author":"JE Pope","year":"2018","unstructured":"Pope JE, Movahedi M, Rampakakis E, Cesta A, Sampalis JS, Keystone E et al (2018) ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI). RMD Open 4(2):e000738","journal-title":"RMD Open"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06548-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06548-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06548-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T07:06:33Z","timestamp":1684739193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06548-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6548"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06548-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"14 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in compliance with ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}